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Abstract: 
 
Background 
More than 300,000 refugees arrived in the United States (U.S.) from 2010-2015, and 
Texas accepts the 2nd highest number of refugees. Texas also accepts large 
numbers of asylees, parolees, and special immigrant visa holders. Additionally, a 
large proportion of trafficked persons in the U.S. live in or pass through Texas. 
Foreign-born children are disproportionately affected by tuberculosis (TB) and 
account for two-thirds of U.S. childhood TB cases. Children are at greater risk for 
progression from TB infection to disease and experience greater morbidity and 
mortality from TB disease. This makes screening for and treatment of TB infection in 
children from high-prevalence areas an important public health intervention. Since 
2007, children 2-14 years old emigrating from high-prevalence countries (TB 
incidence >20 cases /100,000 persons) have been tested for TB infection. Children 
≥15 years old are additionally screened with a chest radiograph. The Centers for 
Disease Control and Prevention (CDC) recommends treatment of children with TB 
infection, as treatment reduces the risk of life threatening disease and prevents 
future transmission. There are few studies describing the epidemiology of TB in 
internationally displaced children relocating to the U.S.; there have been no studies 
centered on Texas. We describe the secular trends and comparative epidemiology 
of positive TSTs and IGRAs in children of different immigration statuses cared for 
through the Houston-area public health program.   
 
Methods  
This was a retrospective cross-sectional study of children <18 years-old evaluated 
by the Harris County Public Health Refugee Health Screening Program between 
January 1st, 2010 and December 31st, 2015 with the following immigration statuses: 
refugee, asylee, parolee, special immigrant visa holder, or victim of human 
trafficking. We analyzed factors associated with TB test positivity, infection and 
disease for children with these immigration statuses. Data are from the U.S. 
Committee for Refugees and Immigrants (USCRI), the Harris County Public Health 
Refugee Health Screening Program, and the Texas Children's Hospital TB clinic. 
Chi-square test or Fisher’s exact test were used for dichotomous variables, one-way 
  
ANOVAs for univariate analyses, and Wilcoxon rank sum or Kruskal-Wallis for 
continuous variables. Multivariate logistic regression was performed to further 
analyze factors associated with TB test positivity. To assess secular trends in usage 
and positivity, monthly totals were analyzed using linear regression and the 
Wilcoxon Sign Rank test.  A p-value <0.05 was considered significant.  Children < 5 
years were typically tested using tuberculin skin test (TSTs) and older children 
typically using interferon-gamma release assays (IGRAs). The primary outcome was 
a positive test of TB infection (TST and/or IGRA). Children who were TST+/IGRA- 
with no known contacts, a normal chest radiograph and no signs or symptoms 
consistent with TB disease were typically considered uninfected. However, there 
were some children who met these criteria who were considered to have TB 
infection and were treated as such –this typically occurred earlier in the study period, 
and was most commonly due to young age (< 2 years old) or some variability in 
provider practice. 
 
Results 
The program evaluated 5,990 children, of whom 5870 (98%) were tested, 
predominantly (64%) with an IGRA alone. During the study period, IGRA use 
increased (p<0.001), though percentages of positive test results (IGRA or TST) did 
not decline significantly (p=0.10). Overall, 364 (6.2%) children had at least one 
positive test of infection: 143/1,842 (7.8%) tested with TST alone, 129/3,730 (63.6%) 
tested with IGRA alone, and 92/298 (30.9%) had at least one positive test result for 
those tested with both TST and IGRA. Among the 364 children with any positive test 
of infection, 4 (1.1%) were diagnosed with TB disease, 325 (89.3%) were diagnosed 
with TB infection, and 35 (9.6%) were considered uninfected. Three factors were 
significantly associated with a positive TST or IGRA result: region of origin, younger 
age group, and HIV infection. All children were more likely to have a positive TST 
compared to IGRA (OR 2.92, 95% CI: 2.37-3.59). Discordant test results were 
common (20%) and most often were TST+/IGRA- (95.0%). 35/57 (61.4%) of children 
who were TST+/IGRA- were considered uninfected and did not receive therapy for 
TB infection; none developed TB disease. The 22/57 (38.6%) TST+/IGRA- children 
who were treated for TB infection, were treated as such typically due to young age 
(< 2 years old) or variability in provider practice. 
 
Conclusions 
Positive TST results were twice as common as positive IGRA results and discordant 
TST/IGRA results were common. Positive TST results in BCG-immunized children 
frequently represent cross-reactivity and false positivity. Use of IGRAs as opposed 
to TSTs in BCG-immunized children would reduce false positive tests and allow for 
TB infection therapy to be targeted to those who would most benefit. These findings 
support 2018 changes in U.S. immigration guidelines that mandate IGRA use for 
recently immigrated children above 2 years of age. 
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BACKGROUND  
Literature Review  
Epidemiology of Tuberculosis (TB) in Children: 
TB remains a significant problem for children throughout the world. The World Health 
Organization estimates there are 1 million cases and 234,000 deaths from TB annually 
among children [1]. Recent mathematical modeling studies demonstrated even higher 
rates with an estimated 67,000,000 children <15-years-old infected with Mycobacterium 
tuberculosis worldwide [2]. In the United States (U.S.), rates of TB disease have been 
declining in all pediatric age groups. However, non-U.S. - born children are 
disproportionately affected; foreign-born children 5-9 years old have rates of TB disease 
13times higher than U.S.-born children [3]. Given these disproportionate rates, 
screening of children for TB infection and disease emigrating from high-prevalence 
areas remains important in the effort to end TB [4].  
 
Tests for TB Infection and Disease 
There are two methods for testing for TB infection: the tuberculin skin test (TST), and 
interferon gamma release assays (IGRAs), both of which are indirect methods to detect 
infection with Mycobacterium tuberculosis that depend on the cellular immune response 
[5]. The tuberculin skin test (TST) depends on a delayed-type hypersensitivity reaction 
(a type of immune response) [5]. Purified protein derivative (PPD) is injected under the 
skin, and the area of induration is assessed at 48-72 hours [5]. It should be 
administered and read by a health care provider with experience, or the interpretation 
can be inaccurate [5]. In children emigrating from high incidence countries (>20 
cases/100,000 persons), the test is considered positive if a child develops induration 
that is 10 mm or greater [5].  Children who have been vaccinated with bacille Calmette-
Guerin (BCG) can have falsely positive TSTs due to cross-reactivity [6]. It is thought that 
this cross-reactivity decreases with age; however, the reaction can be boosted in those 
who have repeated skin testing [7, 8]. 
 
There are two FDA approved IGRAs:  the QuantiFERON TB GOLD (Qiagen, Hilden, 
Germany) and the TSPOT.TB (Oxford Immunotec, Abingdon, UK) [5]. Both tests 
measure interferon-gamma [IFN-γ] production from T lymphocytes in response to M 
tuberculosis antigens [5]. These tests can result as positive, negative, or 
indeterminate/invalid [5]. The 2018 edition of the American Academy of Pediatrics 
Redbook [5] recommends use of IGRAs as the preferred method for TB testing in 
children >2 years-old; however, during the years of the proposed study period, IGRA 
testing was recommended for children > 5-years-old [5, 9].  
 
Important Definitions – Distinguishing Positive Tests of Infection from TB Infection and 
Disease 
A child is determined to have TB infection based on a positive TST or IGRA with a 
normal chest radiograph and no signs or symptoms of disease (described below) [5].  
However, at the Texas Children's Hospital TB Clinic children > 2-years-old who have 
received a BCG vaccine and have a positive TST result but no known contact with a 
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person with pulmonary TB disease, are asymptomatic and have a normal chest 
radiograph are re-tested with an IGRA, most commonly QuantiFERON TB GOLD 
(Qiagen, Hilden, Germany). If the IGRA is negative, the “positive” TST result is most 
likely false (caused by the BCG vaccination), the child is considered uninfected and is 
not treated with anti-TB medications. If the IGRA is positive, the patient is considered to 
have TB infection and is offered treatment.  
 
A child with TB disease is defined as one who has a positive test of TB infection, signs 
and symptoms of disease or a chest radiograph consistent with pulmonary TB, or 
physical exam findings consistent with extra pulmonary TB [5]. TB disease 
manifestations include: fever, prolonged cough, hemoptysis, and night sweats [10]. The 
most common sites of disease include: the lungs (pulmonary and pleural), the central 
nervous system, lymph nodes, and bones/joints [10]. 
 
Internationally Displaced Children and Their Risk-Factors for TB: 
Internationally displaced children often transit from high-prevalence areas and live in 
conditions conducive to acquiring and transmitting M tuberculosis (the causative agent 
of TB) [11-13]. Refugees, asylees, and victims of human trafficking (VHTs) are 
displaced for prolonged periods in difficult contexts that may promote TB transmission. 
At the end of 2015, most refugees from non-Middle Eastern countries to the U.S. had 
lived away from their home countries for an average of 10 years [14]. Living conditions 
for persons with these immigration statuses, and in particular for those living in refugee 
camps, may be below United Nations Developmental Programme standards in 
sanitation and housing, access to healthcare, and access to nutrition, thus placing these 
individuals at increased risk for acquiring TB infection [15]. In contrast, those with 
special immigrant visas (SIVs) frequently are Afghani or Iraqi nationals (and their 
families) who served as translators for the U.S. Armed Forces [16]. As this program 
grew, more upper and middle class persons who likely were at lower risk for acquiring 
TB infection applied for this immigration status [16, 17].  Those with parole status most 
commonly emigrated from Cuba, a country with low incidence of TB, making their risk of 
acquiring TB infection lower [18-20].  
 
Young children have an increased risk of progression from TB infection to disease 
compared to adults, and are a specific population of interest in TB eradication [21]. 
Therefore, effective detection and treatment of TB infection in internationally displaced 
children remain a priority in order to attain adequate disease prevention and control 
[22].  
 
Internationally Displaced Children Resettling in Harris County: 
Between October 2016 and February 2017, more than 37,000 refugees arrived in the 
U.S. Texas is the second largest refugee settlement state in the U.S., with Harris 
Country settling the most refugees in Texas. Approximately 8.5% of refugees to the 
U.S. resettle in Texas annually; 25% of these resettle in Houston [23]. The Harris 
County Public Health Refugee Health Screening Program serves as the largest health-
screening program in Texas [24, 25]. A large proportion of internationally displaced 
children relocating to the U.S. with the immigration status of asylee, parolee, or SIV 
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holder also resettle in Texas. Additionally, Texas - and Houston in particular - are 
considered hubs of human trafficking with more than 300,000 trafficked persons 
residing in the state [26]. However, despite this tremendous activity, there are minimal 
published data on childhood TB infection and disease among these populations.  
 
TB Prevalence Among Internationally Displaced Children Resettling in the U.S.  
Based mainly on TST results, a recent study demonstrated that 12% of children ages 2-
14 years entering the U.S. from high burden countries have TB infection. However, in 
one study, 64% of those who previously tested positive were re-tested post-immigration 
and the diagnosis of TB infection was changed from positive to negative for 71% of 
those re-tested by IGRA [27]. Other studies in refugee children resettling in the U.S. or 
Australia found rates of TB infection ranging between 9%-35.2% when only the TST 
was used [28-32].  
 
TB Screening in the U.S. 
A recent study evaluating TB screening in refugee children in high-immigration, low-
incidence countries found that no two countries had the same approach to TB screening 
[33].   
 
In 2007, the CDC updated the pre-immigration recommendations for TB screening for 
immigrants to the U.S. Now, all children ages 2-14 years who live in countries with an 
estimated incidence rate of >20 cases/100,000 persons are supposed to be screened 
with either a TST or IGRA [34, 35]; children < 2 years of age receive no screening. 
However, this does not occur consistently, and results or paperwork are often missing 
on arrival. As a result, in Houston, the Harris County Public Health Refugee Health 
Screening Program performs intake TB screening, HIV testing, and pathogenic parasite 
screening for all refugees, asylees, VHTs (that are identified), parolees, and SIV holders 
that resettle in the county if this testing was not previously done and/or if there is no 
documentation of prior testing.  
 
Public Health Significance 
Harris County’s prevalence of internationally displaced children allows for the study of 
the prevalence of positive tests of TB infection in this unique population. This study will 
describe the secular trends, comparative epidemiology of positive TB tests, and will give 
further insight into the epidemiology of childhood TB infection and disease in 
internationally displaced children arriving to the U.S. This will allow for further 
understanding of risk factors for positive TB tests in the pediatric population.  
  
Hypotheses  
1) Twenty-five percent of high-risk internationally displaced children (refugees, 
asylees, parolees, SIV holder’s and VHTs) age <18 years-old who have resettled 
in Harris County will have a positive test of tuberculosis infection (either TST or 
IGRA). 
2) Presumed higher-risk internationally displaced children (refugees, asylees, and 
VHTs)  < 18 years old who resettled in Harris County between January 1st, 2010 
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and December 31st, 2015 will have a higher prevalence of positive tests of TB 
infection compared to presumed lower-risk internationally displaced children 
(parolees, and SIV holders). 
3) There will be changes in the composition of the study population over the study 
period; specifically the proportion of different immigration statuses, and the 
proportion of persons emigrating from different regions of origin will differ by year.  
a. There will be a 15% increase in the percentage of children who are tested 
for TB infection with an IGRA compared to a TST over the study period. 
b. There will be a 5% decrease in the percentage of children who have a 
positive test of TB infection over the study period.  
Specific Aims 
 
1) Describe and analyze the epidemiology of positive tests of TB infection and TB 
disease among internationally displaced children (refugees, asylees, parolees, 
SIV holders, and VHTs) age < 18 years who have resettled in Harris County 
between January 1st, 2010 and December 31st, 2015. 
2) Compare the prevalence of positive tests of TB infection for those with presumed 
higher-risk immigration statuses (refugees, asylees, and VHTs) to those with 
lower-risk statuses (parolees and SIV holders).  
3) Describe and evaluate secular trends of different immigration statuses over the 
study period. 
a. Describe and evaluate secular trends of the types of TB testing performed 
and the rates of positive tests of infection.  
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METHODS 
Study Design 
This is a retrospective cross-sectional study evaluating the epidemiology, secular trends, 
and variables which may impact rates of positive tests of TB infection among 
internationally displaced children. Parameters evaluated were: age, sex, year of arrival, 
region of origin, HIV status, pathogenic parasite status, and other underlying medical 
conditions. For those with positive TST or IGRA result, we evaluated the size of induration 
for positive TST, and/or the numerical value of the positive IGRA.  TSTs were considered 
positive if there was ≥ 10mm of induration unless children were HIV-infected, in which 
case ≥ 5mm of induration defined a positive TST result. For the IGRAs, per 
manufacturers’ recommendations: a TSPOT.TB (Oxford Immunotec, Abingdon, UK) test 
was defined as positive if ≥ 8 spots were noted in either well; a QuantiFERON (Qiagen, 
Hilden, Germany) test was defined as positive if the antigen-nil value was  > 0.35 IU/ml 
[36].  A retrospective review was performed to calculate and compare the prevalence of 
positive tests of TB infection in presumed higher-risk (refugees, asylees, and VHTs) 
compared to presumed lower-risk (parolees and SIV holders) internationally displaced 
children <18 years arriving in Harris County between January 1st, 2010 and December 
31st, 2015. A de-identified database which includes the child’s sex, age at arrival, country 
of origin, type of TB test performed and the results, HIV status, and pathogenic parasite 
status was provided by the U.S. Committee for Refugees and Immigrants (USCRI).  
 
Additional clinical data were abstracted from the Harris County Public Health Refugee 
Health Screening Program and the Texas Children’s Hospital Electronic Medical Records 
(EMRs) via patient chart review. IRB approval was obtained from the Harris County 
Health Department and Baylor College of Medicine.  
 
All patients were assigned a study ID number. Study ID numbers that linked the 
corresponding patient identifying information were stored separately on a Texas 
Children's Hospital password protected workstation in a locked office.  
 
Study Setting 
1) Harris County Public Health Refugee Health Screening Program 
2) Texas Children's Hospital TB Clinic 
 
Study Subjects 
Children < 18 years-old evaluated by the Harris County Public Health Refugee Health 
Screening Program between January 1st, 2010 and December 31st, 2015 with the 
following immigration statuses: refugee, asylee, SIV holder, parolee and VHT.  
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Inclusion criteria: 
 Refugee, asylee, SIV holder, parolee, and VHT children age < 18 years who have 
resettled in Harris County between 1/1/2010 and 12/31/2015.  
 
Exclusion criteria: 
 Any person > 18 years 
 Any person who did not fall under the following classifications: refugee, asylee, SIV 
holder, parolee, or VHT.  
 
Sample Size 
5990 children < 18 years old were evaluated by the Harris County Public Health 
Refugee Health Screening Program between January 1st, 2010 and December 31st, 
2015 with the previously mentioned immigration statuses.  
 
Data Collection 
A de-identified database which includes all children <18 years-old who were evaluated 
by the Harris County Public Health Refugee Health Screening Program between 
January 1st, 2010 and December 31st, 2015 was provided by USCRI. Variables in the 
database include: the child’s sex, age at arrival, date of arrival, country of origin, type of 
TB test performed and the test results, HIV status, and pathogenic parasite status. 
Further clinical data were abstracted from the Harris County Public Health Refugee 
Health Screening Program and the Texas Children’s Hospital EMRs via patient chart 
review. To identify patients by name and date of birth, a retrospective review of the 
Harris County Public Health Refugee Health Screening Program EMR was performed. 
Patients were matched to the pre-existing database provided by USCRI by: age at 
arrival, date of arrival, country of origin, sex, and TB test result (TST induration and if 
the IGRA result was positive or negative – numerical value not provided). Children were 
matched in the Texas Children's Hospital EMR by name and date of birth (Figure 1).   
 
Further clinical data from the Texas Children's Hospital needed to complete this project 
included: presence of medical comorbidities; the quantitative value of the IGRA; and 
chest radiograph result. IRB approval has been obtained from both of these institutions 
(Figure 1).  
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Figure 1. Flow diagram of data-abstraction procedures  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
De-identified Database from USCRI, with the following information: 
Sex 
Age at arrival 
Date of arrival 
Country of origin 
Type of TB test and result (TST numerical value, IGRA 
positive/negative/indeterminate/invalid) 
HIV status 
Pathogenic parasite status 
 
Patient’s names and dates of birth obtained by matching the following 
information from the USCRI database to the Harris County Public Health 
Refugee Health Screening Program EMR: 
Sex 
Age at arrival 
Date of arrival 
Country of origin 
Type of TB test and result (TST numerical value, IGRA 
positive/negative/indeterminate/invalid) 
Further Information needed from Texas Children's Hospital EMR 
Presence of medical comorbidities 
Quantitative value of the IGRA 
Chest radiograph result 
Linked to Texas Children's 
Hospital by patient name and date 
of birth 
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Data Analysis 
Demographic characteristics among the higher-risk groups and lower-risk groups were 
compared for statistically significant differences by the Chi-square test or Fisher exact 
test for dichotomous variables and Wilcoxon rank sum or Kruskal-Wallis for continuous 
variables. Categorical variables were compared between testing results using Chi-
square or the Fisher exact test. Multivariate logistic regression was performed to 
determine correlates of positive TSTs and IGRAs. Three models were created to 
determine what factors were independently associated with positive tests of infection: a 
positive TST result, a positive IGRA result, and any positive TB test result (TST or 
IGRA).  Any factor with a p-value ≤0.25 was included in the binary regression model. 
The final model was created using a backward-step approach. To assess secular trends 
in usage and positivity, monthly totals were analyzed using linear regression and the 
Wilcoxon Sign Rank test.  A p-value <0.05 was considered significant.  
 
All analyses were conducted using the Statistical Package for the Social Sciences 
(SPSS), version 25 (IBM Corp.; Armonk, NY).  Institutional review board approval was 
obtained from the Harris County Public Health Department, Baylor College of Medicine, 
and the UTHSC Committee for Protection of Human Subjects.  
 
Human Subjects Considerations  
De-identified patient information was obtained from USCRI. Patient names and dates of 
birth were obtained from the Harris County Public Health Refugee Health Screening 
Program in order to link patients between the Harris County Public Health Refugee 
Health Screening Program and Texas Children's Hospital EMRs. All data were stored 
electronically and were de-identified by assigning patients a study ID number and 
having patient identifiers linked to their study ID stored separately on a password 
protected database. All data were electronic and no physical data exist. All data were 
abstracted from medical records onto password-protected Texas Children’s Hospital 
workstations located in locked offices. IRB approval was obtained from Baylor College 
of Medicine, the Harris County Department of Health, and the UTHSC Committee for 
Protection of Human Subjects.  
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Abstract: 
 
Background 
United States guidelines recommend testing children emigrating from high tuberculosis-
incidence countries with tuberculin skin tests (TSTs) or interferon-gamma release 
assays (IGRAs). We describe a large refugee program’s testing results.  
 
Methods  
This was a cross-sectional study of all children <18 years old evaluated by a refugee 
program from 2010-2015. Children < 5 years were typically tested using TSTs and older 
children typically using IGRAs. The primary outcome was a positive test of TB infection 
(TST and/or IGRA). Children who were TST+/IGRA- with no know contacts, a normal 
chest radiograph and no signs or symptoms consistent with TB disease were typically 
considered uninfected. However, there were some children who met these criteria who 
were considered to have TB infection and were treated as such – this typically occurred 
earlier in the study period, and was most commonly due to young age (< 2 years old) or 
some variability in provider practice.  
 
Results 
The program evaluated 5,990 children, of whom 5870 (98%) were tested, predominantly 
(64%) with an IGRA alone. During the study period, IGRA use increased (p<0.001), 
though percentages of positive test results (IGRA or TST) did not decline significantly 
(p=0.10). Overall, 364 (6.2%) children had at least one positive test of infection: 
143/1,842 (7.8%) tested with TST alone, 129/3,730 (63.6%) tested with IGRA alone, 
and 92/298 (30.9%) had at least one positive test result for those tested with both TST 
and IGRA. Among the 364 children with any positive test of infection, 4 (1.1%) had TB 
disease, 325 (89.3%) TB infection, and 35 (9.6%) were considered to be uninfected. 
Three factors were significantly associated with a positive TST or IGRA result: region of 
origin, younger age group, and HIV infection. All children were more likely to have a 
positive TST compared to IGRA (OR 2.92, 95% CI: 2.37-3.59). Discordant test results 
were common (20%) and most often were TST+/IGRA- (95.0%). 35/57 (61.4%) of 
children who were TST+/IGRA- were considered uninfected and did not receive therapy 
for TB infection; none developed TB disease. The 22/57 (38.6%) TST+/IGRA- children 
who were treated for TB infection, were treated as such typically due to young age (< 2 
years old) or variability in provider practice.  
 
Conclusions: 
Positive TST results were twice as common as positive IGRA results and discordant 
TST/IGRA results were common. These findings support the 2018 change in U.S. 
immigration guidelines that mandate IGRA use for recently immigrated children.  
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Background: 
The World Health Organization (WHO) estimated there were 1 million tuberculosis (TB) 
cases and 234,000 deaths among children in 2017 [1]. An estimated additional 67 
million children are infected with Mycobacterium tuberculosis [2]. Testing of children 
emigrating from high- to low-prevalence countries can provide benefit to individual 
patients (by reducing the risk of progression to disease) and to the community (by 
decreasing the reservoir for future disease cases).  
 
Not all recently arrived children are at equal risk of TB infection. Refugees, asylees, and 
victims of human trafficking (VHTs) may be at highest risk, due to prolonged periods of 
displacement and residence in facilities with crowding, under nutrition, poor sanitation 
and poor access to medical care [3]. Special immigrant visa (SIV) holders are 
predominantly children of Afghani or Iraqi nationals who served as military translators 
and are of higher socioeconomic status (SES) [4-5], potentially placing them less at risk 
for TB exposure. Those with parole status most commonly emigrated from Cuba, a 
country with low incidence of TB [6-8].  
 
In 2018, the Centers for Disease Control and Prevention (CDC) updated the pre-
immigration guidelines for TB testing for immigrants to the U.S., recommending that 
children ages 2-14 years who come from high TB-incidence countries (>20 
cases/100,000) be tested with an interferon-gamma release assay (IGRA) [9].  
 
Previously, due to resource restrictions, tuberculin skin tests (TSTs) were performed 
more commonly in many countries, and 9-35% of refugee children tested positive [10-
15]. However, in one large study almost two-thirds of children with positive pre-
immigration TST results had negative IGRA results on post-immigration testing [11], 
indicating that many positive TST results likely are caused by prior vaccination with the 
bacillus Calmette-Guérin (BCG).  
 
Almost 10% of refugees, asylees, parolee, or SIV holders resettle in Texas, with almost 
25% of these refugees resettling in Harris County (Houston) [16]. Additionally, Texas is 
a human trafficking hub, with more than 300,000 trafficked persons passing through the 
state [17]. We describe the secular trends and comparative epidemiology of positive 
TSTs and IGRAs in children of different immigration statuses cared for through the 
Houston-area public health program.   
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Methods: 
The Harris County Public Health Refugee Health Screening Program performs intake 
TB, HIV, and pathogenic parasite testing for all refugees, asylees, identified victims of 
human trafficking (VHTs), parolees, and SIV holders resettling in the county. This was a 
cross-sectional study of 0-18-year-old children evaluated by this program between 
January 1st, 2010 and December 31st, 2015. We obtained demographics, TB exposure 
history, symptom screening, and testing results from the refugee program and the U.S. 
Committee for Refugees and Immigrants (USCRI). These data were linked to data 
obtained from the Texas Children’s Hospital TB Clinic to evaluate testing outcome and 
diagnoses.  
 
Immigration status was determined by USCRI (Table 1). We hypothesized that 
refugees, asylees, and VHTs would be higher-risk groups for TB infection, as they were 
more likely to have lived in congregate settings. We predicted the lower-risk groups to 
be parolees and SIVs due to residence in lower TB-incidence nations and higher SES, 
respectively. We used WHO definitions for regions of origin [18].  
 
Initial TB testing in the Harris County program typically used TSTs in children < 5-years-
old and IGRAs in children > 5 years-old. TST results were considered positive if there 
was ≥ 10mm of induration unless children were HIV-infected, in which case the 
threshold was ≥ 5mm of induration [19]. The main IGRA used was the T-SPOT.TB 
(Oxford Immunotec; Abingdon, UK), which was defined as positive if ≥ 8 spots were 
noted in either well [20]. A positive QuantiFERON Gold-In Tube (Qiagen; Hilden, 
Germany) was defined as an antigen-nil value of > 0.35 IU/ml [20].  
 
Children with positive test(s) of infection were classified as TB infected, TB uninfected, 
or having TB disease. These classifications were determined by two pediatric TB 
experts. In the first 2 categories, children had normal physical examinations and 2-view 
chest radiographs. Children were defined as having TB infection if they had a 1) IGRA+ 
or 2) TST+ result and no IGRA was done (not all TST+ children had IGRAs performed), 
or if the IGRA result was indeterminate/invalid. We typically defined children as being 
uninfected if they had a negative TST and/or IGRA, or received a BCG vaccine, were 
TST+/IGRA- and had no known contacts with TB disease. However, not all children who 
were TST+/IGRA- were classified as being uninfected; some of these children were 
classified as having TB infection (based on TB clinic note)- and were treated as such, 
most commonly due to young age and some variability on provider practice. TB disease 
was diagnosed in children with clinical, examination, or radiographic findings consistent 
with TB [21].   
 
Three models were created to determine what factors were independently associated 
with positive tests of infection: a positive TST result, a positive IGRA result, and any 
positive TB test result (TST or IGRA). Demographic characteristics among the higher-
risk groups and lower-risk groups were compared for statistically significant differences 
by the Chi-square test or Fisher exact test for dichotomous variables and Wilcoxon rank 
sum or Kruskal-Wallis for continuous variables. Categorical variables were compared 
between testing results using Chi-square or the Fisher exact test.  Any factor with a p-
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value ≤0.25 was included in the binary regression model. The final model was created 
using a backward-step approach. To assess secular trends in usage and positivity, 
monthly totals were analyzed using linear regression and the Wilcoxon Sign Rank test.  
A p-value <0.05 was considered significant.  
 
All analyses were conducted using the Statistical Package for the Social Sciences 
(SPSS), version 25 (IBM Corp.; Armonk, NY).  Institutional review board approval was 
obtained from the Harris County Public Health Department and Baylor College of 
Medicine.  
 
Results: 
During the study period, the refugee program evaluated 5,990 children (Table 2), 98% 
(5,870) of whom received at least 1 test of TB infection (Table 3): IGRA (3,730, 63.6%); 
TST (1,842, 31.4%); and both TST and IGRA (298, 5.1%). In the latter group, 29/298 
(9.7%) were TST+/IGRA+, 57 (19.1%) TST +/IGRA -, 3 (1.0%) TST+/IGRA 
indeterminate/invalid, and 3 (1.0%) TST-/IGRA + (Figure 1). Discrepant test results 
occurred in in 60 (20.0%) of children tested with both a TST and an IGRA. Among 
children with discrepant test results: 3 (5.0%) were TST-/IGRA+, and 57 (95.0%) were 
TST+/IGRA-. Overall there were 364 children (6.2%) with at least one positive TB test. 
Among those children with any positive TB test, 4 (1.1%) children were diagnosed with 
TB disease, 325 (89.3%) were diagnosed with TB infection, and 35 (9.6%) were 
considered uninfected (Figure 1). The 35 children who were considered uninfected 
were all TST+/IGRA-. There were additionally 22 (38.6%) children who were 
TST+/IGRA- that were classified as having TB infection, typically earlier in the study 
period because of young age (< 2-years-old), and/or variability in provider practice 
(Figure 1). The Texas Children’s Hospital TB Clinic sees most children in Harris County 
with TB disease, and per chart review, none of these children developed TB disease. 
Further, we cross-referenced the public health records for Harris County and also found 
that none of these children had developed disease.   
 
Positive TST results:  
Three factors were significantly associated with a positive TST result: region of origin, 
age group, and HIV infection. Children from Eastern Mediterranean countries (aOR = 
0.48 [95% CI 0.33 -0.70]) and the Americas (aOR = 0.19 [95% CI 0.09 – 0.39]) had 
reduced odds for a positive TST result compared to children from Southeast Asia 
(Table 4).  Children ages 2-5 years had reduced odds for a positive TST result when 
compared to children <2 years old (aOR = 0.40 [95% CI 0.26 – 0.61]). On univariate 
analysis, there were significant differences in positive TST results in children with 
different immigration statuses; however, these differences were not seen after logistical 
modeling. Children with HIV had increased odds for a positive TST result (aOR = 2.99 
[95% CI 1.01 – 8.87]) (Table 4).  
 
Positive IGRA results:  
There were two factors associated with a positive IGRA result: age group and region of 
origin.  Children from Eastern Mediterranean countries (aOR = 0.34 [95% CI 0.21 -
0.53]), and the Americas (aOR = 0.12 [95% CI 0.06 – 0.25]) had reduced odds for a 
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positive IGRA result compared to children from Southeast Asia (Table 4).  Children 
ages 2-10 years had reduced odds for a positive IGRA result when compared to 
children less than 2 years (2-5 years aOR 0.26 [95% CI 0.11-0.60]; 6-10 years aOR 
0.41 [95% CI 0.20-0.85]). On univariate analysis, there were significant differences in 
positive IGRA results in children with different immigration statuses, however, these 
differences were not seen after logistical modeling. HIV infection was not associated 
with a positive IGRA result (Table 4).  
 
Either positive TST or IGRA result: 
Three factors were associated with a positive TST or IGRA result: region of origin, age 
group, and HIV infection.  Children from Eastern Mediterranean countries (aOR = 0.44 
[95% CI 0.33 -0.59]) and the Americas (aOR = 0.14 [95% CI 0.08 – 0.23]) had reduced 
odds for a positive TST or IGRA result compared to children from Southeast Asia 
(Table 4).  Children ages 2-14 years had reduced odds for a positive TST or IGRA 
when compared to children less than 2-years (2-5 years aOR = 0.36 [95% CI 0.24-0.54]; 
6-10 years aOR = 0.28 [95% CI 0.18-0.42]; 11-14 years aOR = 0.55 [95% CI 0.48-
1.10]). Children with HIV infection had increased odds for a positive TST or IGRA result 
(aOR = 5.57 [95% CI 2.23 – 13.90]) (Table 4). Pathogenic parasite status was not 
associated with either a positive TST or IGRA result (p=0.36) 
 
Positive results for TST vs IGRA: 
Children from all regions and age groups had greater odds of having a positive TST 
result than a positive IGRA result (OR 2.92 [95% CI 2.79-3.59]). Using the IGRA result 
as the reference, the odds of having a positive TST result were greater in children from: 
Eastern Mediterranean countries (OR 3.99 [95% CI 2.59-6.16]), the Americas (OR 4.15 
[95% CI 1.62-10.62]); Southeast Asia (OR 2.96 [95% CI: 2.11-4.15]), and Africa (OR 
2.74 [95% CI 1.95-3.84]) (Figure 2a). Children ages 6-10 years had the greatest odds 
of having a positive TST result compared to a positive IGRA result (OR 5.47 [95% CI 
3.45-8.69]). Children < 2 years had 3.2 times the odds of having a positive TST result 
compared to the IGRA result (95% CI 1.58-6.48), and those ages 11-14 and >14 years 
had approximately 2.5 times the odds of having a positive TST result and a negative 
IGRA result (95% CI 1.60-9.94 and 1.47-4.07 respectively) (Figure 2b). 
 
Secular Trends: 
Demographic secular trends are shown in Figure 3. There was a significant difference 
between monthly TST and IGRA test results using a matched monthly analysis 
(Wilcoxon Sign Rank and Paired t-Test).  IGRA testing was utilized more often than TST 
(Median number of tests per month: 61 vs. 25, respectively) (p-value<0.001) (Figure 4). 
Through linear regression modeling, the slope of monthly IGRA tests significantly 
increased over time (y = 0.94x + 21.53) (p-value<0.001) (Figure 5a).   Percentages of 
positive results (IGRA or TST) appeared to decrease over time but were not significant 
(y = -0.035x + 7.28) (p-value = 0.10) (Figure 5b). 
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Discussion:  
In the U.S., 66% of reported TB cases occur among the foreign-born, a rate 13 times 
higher than for U.S.-born persons [22]. Previous studies mostly utilizing the TST found a 
prevalence of TB infection of 9-35% among refugee children [10-15]. However, positive 
results were less common in our cohort, potentially due to expanded IGRA use and the 
variety of immigration statuses included.  
 
We found that the prevalence of positive TB test results varied by region of origin, age, 
and HIV status, and that all children had greater odds of having a positive TST result as 
compared to IGRA regardless of region of origin or age. We also found discordances 
between TST and IGRA results across the pediatric age spectrum, suggesting that the 
impact of BCG vaccination on TST positivity may be more prolonged than often 
expected.  
 
Region of origin was an important risk factor for positive TB test results: children from 
Southeast Asia had greater odds of having a positive TST and/or IGRA result compared 
to children from Eastern Mediterranean countries and the Americas. Presuming positive 
TB test results represent true TB infection, this is consistent with known epidemiologic 
risk factors - the prevalence of TB disease in Southeast Asia is higher than in Eastern 
Mediterranean countries and Cuba (where most children from the Americas region 
originated) [23].  
 
Age was another important risk factor for positive TB test results. Children <2 years and 
> 14 years had higher prevalence of positive TST and/or IGRA results compared to 
those ages 2-14 years. Older aged children (> 14-years) in our cohort had increased 
prevalence of positive TB test results with both the TST and IGRAs, which more likely 
represent true TB infection because of the children’s greater time outside the home and 
cumulative exposure to adults with infectious pulmonary TB [24-27]. The higher 
frequency of positive tests in children <2 years, on the other hand, is more difficult to 
explain. Higher TST positivity in children <2 years may represent greater cross-reactivity 
with BCG, given the temporal proximity to vaccination or potential boosting if children 
have serial TSTs performed (pre and post immigration); however, this cannot explain 
the increased prevalence of positive IGRAs in these children. Further, these data 
contradict previous studies which demonstrate that older children are more likely to 
have TB infection [24-27]. One explanation is that IGRA positive children <2 years in our 
cohort had more prolonged exposure to an adult family member with infectious 
pulmonary TB in the home, as very young children spend more time in the home 
compared to their school-aged counterparts. To date, IGRAs have not been used 
routinely for the diagnosis of TB infection in children < 2-years-old due to paucity of data 
for their sensitivity [28]. The relatively high prevalence of positive IGRA results in this 
age group may provide some insight for the utility of IGRA use in these younger age 
groups.  
 
Though rare in this cohort, HIV infection was also a significant risk factor for having a 
positive TST result. Consistent with previously published data, HIV has been associated 
with increased risk for TB infection and progression to disease [29], and TB remains an 
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important opportunistic infection, with an incidence of 30% in HIV-infected children in 
low- and middle-income nations [30]. However, the number of HIV-infected children in 
this study was very low, making it difficult to draw meaningful conclusions from these 
data. 
 
Most prior estimates of the prevalence of TB infection in immigrant children used the 
TST as the test of choice, given an initial paucity of pediatric data and the lack of 
availability and cost of IGRAs. A more recent study using IGRA testing estimated that 
5.6% of immigrant children had TB infection compared to 22% using TST [31], and our 
findings paralleled these results. More recent AAP guidelines recommend IGRA use 
down to 2 years of age [28], with some experts using IGRAs in children as young as 1 
year of age. Use of IGRAs rather than the TST in this younger cohort would likely 
reduce false positive tests and allow for TB infection therapy to be targeted to those 
who would most benefit.  
 
The CDC does not recommend tiered testing for TB infection (that is, obtaining an IGRA 
if a TST result is positive). However, there are times when the initial test of infection, 
selected either by choice or by necessity, is not the optimal test, particularly for a BCG-
immunized child. In our study, all children had greater odds of having a positive TST 
result as compared to IGRA regardless of region of origin or age. Additionally, we had 
almost 300 children in whom both TSTs and IGRAs were obtained, of whom 20% had 
discordant results. Our findings are consistent with a prior study that demonstrated that 
for BCG-immunized children who have immigration testing, false positive TST results 
are common, and IGRAs should be the tests of choice for this patient population [10]. 
 
Of note, discordance between TST and IGRA results were seen in all age groups. 
Typically, the impact of BCG vaccine in causing falsely positive TST results has been 
thought to be temporally related to when the child received the BCG vaccine, which in 
most countries is a single dose immediately after birth. However, discordant TST and 
IGRA results even in older children suggest that either the immunogenicity of some 
strains of BCG is longer than previously recognized or that the impact of nontuberculous 
mycobacterial infections, that also can cause a falsely positive TST result, may be 
underestimated in children from developing nations. Concerns about false positive TST 
results are considered in updated 2018 guidelines [9] for TB testing prior to immigration, 
mandating use of IGRAs for all persons 2 years and above.   
 
This study has several limitations. Though we have follow-up data for most children 
evaluated for a positive test of TB infection, as they were seen in our clinic, we do not 
have data for some children evaluated post intake-testing at other clinics, or for children 
whose test for TB infection was negative. BCG vaccination status was not routinely 
documented, thus the presumption of falsely positive TSTs secondary to cross-reactivity 
with BCG assumes that the vast majority of children were BCG-immunized as they 
originated from countries with high BCG-uptake. BCG vaccination is recommended in 
the national immunization program of 95% of countries from which these children 
emigrated [32]. HIV infection was rare in this cohort, thus it is difficult to make 
meaningful conclusions regarding TST and/or IGRA positivity in HIV-infected children 
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from our data. Finally, these data may not be generalizable to all immigrant children 
relocating to the United States, as this study predominately included children from TB 
high-burden countries [9]. 
 
Conclusions:  
The prevalence of positive TB test results in this cohort of children was lower than 
previously reported (compared to studies that predominately used the TST), and TB 
disease was rare. The lower prevalence of positive tests of TB infection in this childhood 
population likely stems from the predominant use of IGRA testing. Despite these low 
rates of positive results, it remains important to screen children emigrating from high-
burden countries. Region of origin, and age are important risk factors for having a 
positive TB test. The TST and IGRAs are frequently discrepant, particularly among 
younger children who have received a BCG vaccine, and those from lower-burden 
countries. Positive TST results in BCG-immunized children frequently represent cross-
reactivity and false positivity. Use of IGRAs as opposed to the TST in BCG-immunized 
children would reduce false positive test results and allow for TB infection therapy to be 
targeted to those who would most benefit.   
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Figures and Tables: 
 
Figure 1. Consort diagram of TST and IGRA Results in Migrant Children Over a 5-Year Period in Harris County, Texas 
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2a                2b   
 
 
Figures 2a and 2b. Comparison of TST and IGRA Results (using IGRAs as reference) in Migrant Children Over a 5-Year Period in  
Harris County, Texas
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 Figure 3. Demographic variables of Migrant Children Over a 5-Year Period in Harris County, Texas 
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Figure 4. Graph of TST and IGRA Utilization in Migrant Children Over a 5-Year Period in Harris County, Texas 
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Figure 5a. Graph of IGRA Monthly Totals Overtime and Figure 5b. Graph of Monthly Positive TB Results (TST & IGRA) in Migrant Children  
Over a 5-Year Period in Harris County, Texas
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Table 1. Definitions of immigration statuses 
Immigration status Definition 
 
 
Refugee 
A person located outside of the U.S. who demonstrates they 
were persecuted or have a fear of persecution due to race, 
religion, nationality, political opinion, or membership in a 
particular social group and is not firmly resettled in another 
country [33]. 
 
Asylee (Asylum seekers)  
Any person who meets the definition of a refugee and is already 
in the United States or seeking admission at a port of entry [34]. 
 
Parolee (The Cuban and Haitian 
Family Reunification Parole 
Programs)   
Persons from Cuba and Haiti who have family members that 
are U.S. citizens or lawful permanent residents, who are able to 
come to the U.S without waiting for immigrant visas to become 
available [35].  
 
 
Special Immigrant Visa holders 
There are many categories of SIVs, however, the children 
included in this study are children of Iraqi and Afghan 
translators are interpreters who have worked with the U.S. 
Armed Forces or under the Chief of Mission authority at the 
U.S. Embassy in Baghdad or Kabul [36]. 
 
Victim of Human Trafficking  
A person who has been recruited, harbored, or transported for 
compelled labor or commercial sex acts through the use of 
force, fraud, or coercion [37].  
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Table 2. Demographic Variables of Migrant Children Over a 5-Year Period in Harris County, Texas  
  Higher-risk groups Lower-risk groups P-value 
Immigration 
Status 
  REFUGEE 
(N=4,246) 
ASYLEE 
(N=173) 
VHT 
(N=16) 
PAROLEE 
(N=851) 
SIV HOLDER 
(N=704) 
 
Category VARIABLE N (%) N (%) N (%) N (%) N (%) 
 
 
 
Demographics 
AGE  
(MEDIAN, IQR) 
8 (4-12) 9 (5-12) 11.5 (7-15) 9 (5-13) 4 (2-8) <0.001 a 
FEMALE 2,025 (47.7%) 81 (46.8%) 7 (43.8%) 404 (47.5%) 304 (43.2%) 0.281 b 
 
 
 
 
WHO Region of 
Origin 
EASTERN 
MEDITERRANEAN 
1,414 (33.3%) 89 (51.4%) 0  0  704 (100.0%) <0.001 b 
SOUTHEAST ASIA 1,416 (33.3%) 7 (4.0%) 1 (6.3%) 0  0  
 
AFRICA 1,202 (28.3%) 40 (23.1%) 0  0 0  
 
AMERICAS 183 (4.3%) 31 (17.9%) 12 (75.0%) 851 (100.0%) 0  
 
WESTERN PAC 18 (0.4%) 2 (1.2%) 1 (6.3%) 0  0  
 
EUROPEAN  13 (0.3%) 4 (2.3%) 2 (12.5%) 0  0  
 
 
 
Comorbidities 
HIV INFECTED 22 (0.5%) 0  0  1 (0.1%) 2 (0.3%) <0.001 b 
PATHOGENIC 
PARASITES 
DETECTED IN 
STOOL 
328 (17.1%) 18 (11.3%) 2 (12.5%) 98 (12.5%) 115 (17.9%) <0.001 b 
 
*% Included reflect those whom the information was available 
a p-value using Kruskal-Wallis 
b p-value using X2 test  
HIV: human immunodeficiency virus; IQR: interquartile range; PAC: Pacific; SIV: special immigrant visa; VHT: victim of human 
trafficking; WHO: world health organization  
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Table 3. Tests TB infection Performed and Test Results by Immigration Status in Migrant Children Over a 5-Year Period in Harris 
County, Texas 
   Higher-risk groups Lower-risk groups P-value 
Immigration 
Status 
  REFUGEE 
(N=4,246) 
ASYLEE 
(N=173) 
VHT 
(N=16) 
PAROLEE 
(N=851) 
SIV 
HOLDER 
(N=704) 
 
        
test(s) of 
Infection 
performed 
TST ALONE 1,381 (32.5%) 30 (17.3%) 1 (6.3%) 168 (19.7%) 300 (42.6%) <0.001 b 
IGRA ALONE 2,558 (60.2%) 137 (79.2%) 15 (93.8%) 642 (75.4%) 349 (49.6%) 
 
TST AND 
IGRA 
204 (4.8%) 4 (2.3%) 0 (0.0%) 22 (2.6%) 29 (4.1%) 
 
test results TOTAL 
POSITIVE 
TESTS 
311 (7.3%) 9 (5.2%) 0 (0.0%) 10 (1.2%) 34 (4.8%) <0.001 b 
IGRA: interferon gamma release assay; SIV: special immigrant visa; TST: tuberculin skin test; VHT: victim of human trafficking  
b p-value using X2 test 
31 
 
 
Table 4. Factors Associated with a Positive TST and/or IGRA Result in Migrant Children over a 5-Year Period in Harris County, 
Texas (n tested = 5,870) 
 
  TST Only  IGRA Only  TST & IGRA Combined 
 N (%) aOR 95% CI P N (%) aOR 95% CI P N (%) aOR 95% CI P 
Age (years) 
<2  
2-5 
6-10  
11-14 
>14  
 
36 (25.2) 
35 (24.5) 
30 (21.0) 
23 (16.1) 
19 (13.3) 
 
Ref 
0.40 
0.72 
0.68 
0.77 
 
 
0.26 – 0.61 
0.42 – 1.25 
0.39 – 1.21 
0.44 – 1.35 
 
 
<0.001 
0.25 
0.19 
0.36 
 
2 (1.6) 
5 (3.9) 
31 (24.0) 
51 (39.5) 
40 (31.0) 
 
Ref 
0.26 
0.41 
1.05 
1.35 
 
 
0.11 – 0.60 
0.20 – 0.85 
0.52 – 2.12 
0.66 – 2.77 
 
 
0.002 
0.02 
0.90 
0.41 
 
55 (15.1) 
81 (22.3) 
74 (20.3) 
85 (23.4) 
69 (19.0) 
 
Ref 
0.36 
0.28 
0.55 
0.72 
 
 
0.24 – 0.54 
0.18 – 0.42 
0.37 – 0.83 
0.48 – 1.10 
 
 
<0.001 
<0.001 
0.004 
0.13 
Region of 
Origin 
SE Asia 
E Med 
Africa 
Americas 
 
 
61 (42.7) 
41 (28.7) 
32 (22.4) 
8 (5.6) 
 
 
Ref 
0.48 
0.69 
0.19 
 
 
0.33 – 0.70 
0.45 – 1.07 
0.09 – 0.39 
 
 
<0.001 
0.10 
<0.001 
 
 
49 (38.0) 
23 (17.8) 
50 (38.8) 
7 (5.4) 
 
 
Ref 
0.34 
1.02 
0.12 
 
 
0.21 – 0.53 
0.70 – 1.49 
0.06 – 0.25 
 
 
<0.001 
0.91 
<0.001 
 
 
148 (40.7) 
98 (26.9) 
100 (27.5) 
17 (4.7) 
 
 
Ref 
0.44 
0.81 
0.14 
 
 
0.33 – 0.59 
0.61 – 1.09 
0.08 – 0.23 
 
 
<0.001 
0.17 
<0.001 
HIV Positive 4 (2.8) 2.99 1.01 – 8.87 0.049 1 (0.8) - - - 7 (1.9) 5.57 2.23 – 13.90 <0.001 
 
N = number in group with a positive TB test result  
E MED: Eastern Mediterranean; SE ASIA: Southeast Asia 
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CONCLUSION 
TB remains a significant public health issue in the U.S. and globally. In the U.S., 66% of 
reported TB cases occur among the foreign-born, a rate thirteen times higher than for 
U.S.-born persons [3]. Previous studies utilizing mainly the TST found a prevalence of 
TB infection of 9-35% among refugee children [27, 37-41]. However, positive results 
were less common in our cohort, potentially due to expanded IGRA use and the variety 
of immigration statuses included.  
 
The prevalence of positive TB test results varied by region of origin, age, and HIV 
status, and all children had greater odds of having a positive TST result as compared to 
IGRA regardless of region of origin or age. Additionally, there were discordances 
between TST and IGRA results across the pediatric age spectrum, suggesting that the 
impact of BCG vaccination on TST positivity may be more prolonged than often 
expected.  
 
Most prior estimates of the prevalence of TB infection in immigrant children used the 
TST as the test of choice, given an initial paucity of pediatric data and the availability 
and cost of IGRAs. A more recent study using IGRA testing estimated that 5.6% of 
immigrant children had TB infection compared to 22% using the TST [42]. More recent 
United States guidelines recommend IGRA use down to 2 years of age [43], with some 
experts using IGRAs in children as young as 1 year of age. Use of IGRAs rather than 
the TST in this younger cohort would likely reduce false positive tests and allow for TB 
infection therapy to be targeted to those who would most benefit.  
 
The CDC does not recommend tiered testing for TB infection (that is, obtaining an IGRA 
if a TST result is positive). However, there are times when the initial test of infection, 
selected either by choice or by necessity, is not the optimal test, particularly for a BCG-
immunized child. In this study, all children had greater odds of having a positive TST 
result as compared to IGRA regardless of region of origin or age. Additionally, three 
were nearly 300 children in whom both TSTs and IGRAs were obtained, of whom 20% 
had discordant results. These findings are consistent with a prior study which 
demonstrated that for BCG-immunized children, on immigration testing, false positive 
TSTs are common, and IGRAs should be the tests of choice for this patient population 
[27]. 
 
Strengths of the study 
The strengths of this study include the large sample size, the comprehensive and 
longitudinal data, and the variety of immigration statuses and countries represented. 
This study represents one of the largest reports of TB testing among the pediatric age 
group resettling in the U.S. Additionally, this study is the only one, to my knowledge, 
that has long term follow up information on these pediatric patients as a result of the 
relationship between the refugee resettlement program and the TCH TB clinic. This 
study offers further insight into the epidemiology of TB infection for children with varied 
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immigration statuses emigrating from high-burden countries, and offers further data on 
the comparison of TSTs and IGRAs in this largely BCG-immunized population.  
 
Limitations of the study 
This study has several limitations. Though follow-up data for most children evaluated for 
a positive test of TB infection was obtained, there are missing data for some children 
evaluated post intake-testing at other clinics, or for children whose test of TB infection 
was negative. BCG vaccination status was not routinely documented, thus the 
presumption of falsely positive TST results secondary to cross-reactivity with BCG 
assumes that the vast majority of children were BCG-immunized as they originated from 
countries with high BCG-uptake. BCG vaccination is recommended in the national 
immunization program of 95% of countries from which these children emigrated [44]. 
HIV infection was rare in this cohort, thus it is difficult to make meaningful conclusions 
regarding TST and/or IGRA positivity in HIV-infected children from our data. Finally, 
these data may not be generalizable to all immigrant children relocating to the United 
States, as this study predominately included children from TB high-burden countries.  
 
Conclusions:  
The prevalence of positive TB test results in this cohort of children was lower than 
previously reported (compared to studies that predominately used the TST), and TB 
disease was rare. The lower prevalence of positive tests of TB infection in this childhood 
population likely stems from the predominant use of IGRA testing. Despite these low 
rates of positive results, it remains important to screen children emigrating from high-
burden countries. Region of origin, and age are important risk factors for having a 
positive TB test result. The TST and IGRAs are frequently discrepant, particularly 
among younger children, and those from lower-burden countries. Positive TST results in 
BCG-immunized children frequently represent cross-reactivity and false positivity. Use 
of IGRAs as opposed to TSTs in BCG-immunized children would reduce false positive 
tests and allow for TB infection therapy to be targeted to those who would most benefit.   
 
Future work: 
For future work I plan to further evaluate discrepancies between the TST and IGRAs in 
BCG-immunized children by expanding the years of the study to include children seen 
at the TCH TB clinic between 2010 and 2017, specifically evaluating children in whom 
both a TST and IGRA were obtained to determine test characteristics. I additionally, 
plan to study factors associated with acceptance and completion of therapy for TB 
infection in this population.  
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